Jefferies maintains SFBC at buy

SFBC International, Inc. was kept at a buy rating by Jefferies & Co., Inc. analyst David Windley. Jefferies lowered its price target to $19 as the company's Miami's issues burden results more than expected. SFBC had a GAAP loss per share of $0.23. Total revenue of $80.1 million was slightly above the analyst's estimate of $78.9 million. Shares of the Princeton, N.J., drug development services company were up $0.10, or 0.63%, at $15.95 on volume of 905,975 shares versus the three-month running average of 886,500 shares. (Nasdaq: SFCC)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.